Pharma R&D & Clinical Services · Indirect
Monitoring · monthlyProcurement Category Intelligence
Real World Evidence Studies
Overview
Market size
$2.8B
global, USD
CAGR
12.5%
base to forecast
Buyer power
-2.0
supplier-favoured
Suppliers
6
tracked players
Signals
12
1 high severity
Market outlook
2031$5.0B
What changed
Demand by region
North America demand45%
Europe demand30%
Asia Pacific demand15%
Rest of world demand10%
share of global demandtotal 100%
Cost drivers
Clinical Data Acquisition and Curation35%
Specialized Personnel and Biostatistics Labor30%
Platform Infrastructure and Analytics Software15%
Regulatory Compliance and Data Governance10%
Project Management and Overhead10%
share of delivered cost (analyst estimate)